Saudis Buy 90,000 Tons of Rice for Zakat al-Fitr

Rice is the common benefactor's choice for end-of-Ramadan charity in Saudi Arabia, Asharq Al-Awsat
Rice is the common benefactor's choice for end-of-Ramadan charity in Saudi Arabia, Asharq Al-Awsat
TT

Saudis Buy 90,000 Tons of Rice for Zakat al-Fitr

Rice is the common benefactor's choice for end-of-Ramadan charity in Saudi Arabia, Asharq Al-Awsat
Rice is the common benefactor's choice for end-of-Ramadan charity in Saudi Arabia, Asharq Al-Awsat

Around 30 million individuals are heading to markets in Saudi Arabia to buy rice for Zakat al-Fitr, charity taken for the poor a few days before the end of fasting in the Islamic holy month of Ramadan.

Rice, a prominent commodity in Saudi Arabia, is the benefactor’s choice to give out as charity.

Usually each individual donates three kilograms of rice for Zakat al-Fitr, which is amounting this year to over 462 million Saudi rials ($123 million). Over 90,000 tons of rice are being distributed to the poor.

According to rice importers, the value of spending fluctuates according to the quality of rice being bought. Most consumers opt to buy rice that sells between 5 and 8 Saudi rials per kilogram.

Mohammed Shalan, the chairman of the board of directors at Abdul Rahman Al Shalan Sons Trading Co, confirmed that rice is the commodity of choice when it comes to distributing Zakat al-Fitr. Estimations indicate that 30 million individuals will be giving out 3 kilograms of rice each this year, Shalan said.

Shalan, whose company is one of the lead rice suppliers in the Kingdom, said that for the two months linked to Ramadan the consumption of rice rises significantly in the Kingdom. During those 60 days, rice consumption rates make up around 30% of the annual consumption volume which is estimated at 1.4 million tons.

The spike in consumption is a reflection of multiple factors. Families in Saudi Arabia consume more rice around Ramadan.

The commodity is integral to Suhoor meals, charity, Eid feasts and Zakat al-Fitr.

As for supply, Shalan reassured that market demand is covered despite the coronavirus pandemic. Demand was secured early on by authorities, who supported the private sector and backed the entry of goods into the Kingdom, which has stabilized the market, Shalan said.



UAE’s Mubadala Acquires Majority Stakes in Global Medical Supply Chain, Al Ittihad Drug

The acquisition enhances Mubadala's footprint in the healthcare logistics and pharmaceutical distribution sectors. WAM
The acquisition enhances Mubadala's footprint in the healthcare logistics and pharmaceutical distribution sectors. WAM
TT

UAE’s Mubadala Acquires Majority Stakes in Global Medical Supply Chain, Al Ittihad Drug

The acquisition enhances Mubadala's footprint in the healthcare logistics and pharmaceutical distribution sectors. WAM
The acquisition enhances Mubadala's footprint in the healthcare logistics and pharmaceutical distribution sectors. WAM

Mubadala Investment Company has acquired an 80% stake in Global Medical Supply Chain (GMSC) and Al Ittihad Drug Store (IDS) from GlobalOne Healthcare Holding (GHH), with GHH retaining a 20% stake, Emirates News Agency (WAM) reported on Tuesday.

This strategic acquisition enhances Mubadala's footprint in the healthcare logistics and pharmaceutical distribution sectors, aligning with the UAE's vision to establish a robust life sciences infrastructure, WAM said.

Founded in 2015, GMSC provides comprehensive end-to-end supply chain services for medical products, including demand planning, procurement, logistics, inventory management, warehousing, and maintenance.

GMSC serves over 200 medical facilities, including hospitals and clinics across the UAE. With a dedicated team of medical supply chain specialists, GMSC sources a broad array of products from almost 400 suppliers, ensuring a reliable supply chain for all medical needs.

IDS, established in 1987, stands as one of the leading distributors of pharmaceutical and consumer healthcare products in the UAE. Distributing over 1,000 products from over 40 leading suppliers, IDS services every hospital, and all, or at least most pharmacies and supermarkets within the UAE. It boasts a vast portfolio that spans multiple therapeutic categories including anti-infectives, asthma, diabetes, and oncology.

"The expanding pharmaceutical market drives an increasing demand for specialized and efficient drug logistics solutions. By integrating GMSC and IDS into our portfolio, we are poised to create a vertically integrated life sciences sector in the UAE and enable its potential to encompass the entire value chain from logistics and distribution to specialized manufacturing,” said Executive Director of UAE Clusters at Mubadala's UAE Investments Platform Ismail Ali Abdulla.

As for Low Ping, Group CEO Yas Holding, she said that the transaction “continues Mubadala's strategic growth, following another significant acquisition by its new speciality pharmaceutical business, KELIX bio, which recently acquired a 100% stake in four pharma assets from GlobalOne Healthcare Holding's, the healthcare division of Yas Holding.”

“These concerted efforts underline Mubadala's commitment to strengthening the UAE's healthcare and pharmaceutical sectors as part of broader national ambitions for drug security and economic diversification."

GlobalOne Healthcare Holding LLC serves as the dedicated Healthcare Division of Yas Holding LLC, focusing on enhancing healthcare outcomes by investing in innovative solutions across various healthcare verticals.